ASCORBIC ACID injection, for intravenous use
- Manufacturer
- Zydus Lifesciences Limited
- Effective date
- 2026-09-03
- Label type
- HUMAN PRESCRIPTION DRUG LABEL
- Version
- 1
- Source
- daily-update
- Hydrated at
- 2026-09-30 01:02:41
Label at a glance#
Label contents#
Full prescribing information#
Product Linked Resources#
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Barcode | EAN-13 | 0370710216412 | GTIN-13: 0370710216412 EAN-13: 0370710216412 GTIN-12: 370710216412 UPC-A: 370710216412 GTIN storage (14 digits): 00370710216412 | db495704-ebb9-4090-b28a-b30b73e10ffa-03.jpg |
Products#
Every source-derived product name is available through these pages.
- Ascorbic acid
- EDETATE DISODIUM
- SODIUM BICARBONATE
- SODIUM HYDROXIDE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 70771-1943 | 70771-1943-8, 70771-1943-9 |
| 70771-1944 | 70771-1944-8, 70771-1944-9 |
| 70771-1945 | 70771-1945-8, 70771-1945-9 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ASCORBIC ACID | PQ6CK8PD0R | ACTIB |
| EDETATE DISODIUM | 7FLD91C86K | IACT |
| SODIUM BICARBONATE | 8MDF5V39QO | IACT |
| SODIUM HYDROXIDE | 55X04QC32I | IACT |
| ASCORBIC ACID | PQ6CK8PD0R | ACTIB |
| EDETATE DISODIUM | 7FLD91C86K | IACT |
| SODIUM BICARBONATE | 8MDF5V39QO | IACT |
| SODIUM HYDROXIDE | 55X04QC32I | IACT |
| ASCORBIC ACID | PQ6CK8PD0R | ACTIB |
| EDETATE DISODIUM | 7FLD91C86K | IACT |
| SODIUM BICARBONATE | 8MDF5V39QO | IACT |
| SODIUM HYDROXIDE | 55X04QC32I | IACT |
Source Document#
Orange Book application contexts#
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A220873-001 | ASCORBIC ACID | ASCORBIC ACID | 2,500MG/5ML (500MG/ML) | SOLUTION / INTRAVENOUS | RS | 2026-08-20 | |
| A220873-002 | ASCORBIC ACID | ASCORBIC ACID | 5,000MG/10ML (500MG/ML) | SOLUTION / INTRAVENOUS | RS | 2026-08-20 | |
| A220873-003 | ASCORBIC ACID | ASCORBIC ACID | 25,000MG/50ML (500MG/ML) | SOLUTION / INTRAVENOUS | AP | 2026-08-20 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A220873-003 | AP |
Orange Book exclusivity#
| Application-product | Exclusivity code | Expiration |
|---|---|---|
| A220873-001 | CGT | 2027-04-24 |
| A220873-002 | CGT | 2027-04-24 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A220873-001 | ASCORBIC ACID | 2,500MG/5ML (500MG/ML) | SOLUTION / INTRAVENOUS | RS | 2026-08-20 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | A220873-002 | ASCORBIC ACID | 5,000MG/10ML (500MG/ML) | SOLUTION / INTRAVENOUS | RS | 2026-08-20 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | A220873-003 | ASCORBIC ACID | 25,000MG/50ML (500MG/ML) | SOLUTION / INTRAVENOUS | AP | 2026-08-20 | d4dbc9d85df4… | |
| 2026-10-15 13:18:30 | 2026-09 | A220873-001 | ASCORBIC ACID | 2,500MG/5ML (500MG/ML) | SOLUTION / INTRAVENOUS | RS | 2026-08-20 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A220873-002 | ASCORBIC ACID | 5,000MG/10ML (500MG/ML) | SOLUTION / INTRAVENOUS | RS | 2026-08-20 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A220873-003 | ASCORBIC ACID | 25,000MG/50ML (500MG/ML) | SOLUTION / INTRAVENOUS | AP | 2026-08-20 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | A220873-001 | ASCORBIC ACID | 2,500MG/5ML (500MG/ML) | SOLUTION / INTRAVENOUS | RS | 2026-08-20 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A220873-002 | ASCORBIC ACID | 5,000MG/10ML (500MG/ML) | SOLUTION / INTRAVENOUS | RS | 2026-08-20 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A220873-003 | ASCORBIC ACID | 25,000MG/50ML (500MG/ML) | SOLUTION / INTRAVENOUS | AP | 2026-08-20 | 84e616aacf4f… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A220873-003 | AP | 1 | d4dbc9d85df4… |
| 2026-10-15 13:18:30 | 2026-09 | A220873-003 | AP | 1 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | A220873-003 | AP | 1 | 84e616aacf4f… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A220873-001 | CGT | 2027-04-24 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | A220873-002 | CGT | 2027-04-24 | d4dbc9d85df4… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ascorbic acid | ASCORBIC ACID | Zydus Lifesciences Limited | d2d29ffd-5483-45bb-9d1b-da7af23b3720 | 2026-09-03 | 70771-1943-8 70771-1943-9 70771-1944-9 70771-1944-8 70771-1945-8 70771-1945-9 70771-1943 70771-1945 70771-1944 70771194509 70771194408 70771194309 70771194308 70771194409 70771194508 db495704-ebb9-4090-b28a-b30b73e10ffa d2d29ffd-5483-45bb-9d1b-da7af23b3720 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.


